Skip to main content

Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales

The results come as Pfizer tries to regain its footing after the rapid decline of its Covid business.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.